News Sentiment

NBTX sentiment intelligence

Nanobiotix news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 68 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 37.79 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

86/100 classification confidence.

Company focus 59

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-5.7% over one week, +4.2% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Nanobiotix Shares Soar Nearly 5%, Targeting Resistance at €36.20

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 86/100 classification
One-week reaction -5.7% Price reacting lower
Trend fit Trend active 4.2% over four weeks
Fair value 213.4% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 45
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 59
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Idéal Investisseur 13
TradingView 13
Market source 10
Stock Titan 7
GlobeNewswire 4
MT Newswires 3
Seeking Alpha 2
TradingKey 2

Event Lens

What the news is about

Classified themes
Market update 48
Earnings 13
Analyst action 4
Balance sheet 2
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 68
Idéal Investisseur Direct company coverage

Nanobiotix Shares Drop 2% and Fall Below Short-Term Moving Averages

Nanobiotix shares dropped by 2.17% to €29.74, falling below their short-term moving averages (MM20 and MM50) and erasing some early week gains. This decline extends a consolidation phase that began after the stock's historical high in mid-May, despite still showing a significant

Tone
Negative 33/100
Event
Market update
Published
19 Jun 2026 14:51
Source
Idéal Investisseur
Simply Wall Street Direct company coverage

Nanobiotix (ENXTPA:NANO) - Stock Analysis

This article provides a detailed stock analysis of Nanobiotix (ENXTPA:NANO), a clinical-stage biotechnology company focused on cancer treatments. It covers the company's valuation, future growth prospects, past performance, financial health, and recent news, including a significa

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 11:41
Source
Simply Wall Street
Idéal Investisseur Direct company coverage

Nanobiotix Shares Climb Over 3%, Leading Gains in the SBF 120

Nanobiotix shares climbed over 3% in mid-morning trading, positioning the French biotech company as a top performer in the SBF 120. This rebound follows a period of consolidation after reaching a record high in mid-May and comes as the Parisian market also trends upward. The stoc

Tone
Positive 71/100
Event
Market update
Published
18 Jun 2026 08:48
Source
Idéal Investisseur
TradingKey Direct company coverage

Nanobiotix SA (NBTX) Institutional Confidence

This article provides details on the institutional confidence in Nanobiotix SA (NBTX), including its current stock price, market cap, and a list of institutional shareholders. It highlights changes in shareholdings for various firms like Johnson & Johnson Innovation-JJDC, Inc., M

Tone
Positive 64/100
Event
Market update
Published
17 Jun 2026 16:40
Source
TradingKey